BORER JOHN J III 4

What Happened
John J. Borer III, a director of Biofrontera Inc. (BFRI), received a grant of 20,000 derivative awards reported as $0.00 on March 4, 2026. The filing reports these as a derivative acquisition (transaction code A) — i.e., an option award rather than an immediate stock purchase — with no cash paid at grant.

Key Details

• Transaction date: 2026-03-04; Form 4 filed 2026-03-06 (timely filing).
• Reported instrument: 20,000 derivative awards (option grant) reported at $0.00.
• Vesting: Options vest in 12 equal monthly installments beginning April 4, 2026 (Footnote F1).
• Other terms: Options with different terms are not included in this report (Footnote F2).
• Shares owned after transaction: Not specified in the filing.

Context
This was an equity award (compensation) reported as a derivative grant, not an open-market purchase or sale. Because the awards vest over time and are not immediately exercised or sold, the grant itself is a compensation action rather than a direct market-facing buy or sell; it should not be taken as a definitive bullish or bearish signal by itself.